Market Research Reports

1.        The US Biotechnology Market Introduction

2.        The US Biotechnology Market Size by Revenue, 2006-2011

3.        The US Biotechnology Market Segmentation By Application, 2006-2011

3.1.        The US Bio-Pharmaceutical/Biologics Market Size and Introduction, 2006-2011

3.1.1. Top Selling Biologic Drugs, 2010

3.1.2. The US Bio-Pharmaceuticals Market Trends And Developments

       Bio-Pharmaceutical Companies Focus on Outsourcing as Short Term Strategy

        High Approvals Increasing the Number of Bio-Pharmaceutical Products

3.1.3. Top US Biopharmaceutical Companies Market Share, 2011

3.1.4. Biologic Drugs Future Projections, 2012-2016

3.1.5. Major Bio-Pharmaceutical Company Profiles

3.1.5.1. Pfizer Inc 

       Company Overview

       Business Strategies

       Financial Performance

3.1.5.2. Merck & Co

       Company Overview

       Business Strategies

       Financial Performance

3.1.5.3. Novartis

       Company Overview

       Business Strategies

       Financial Performance

3.1.5.4. AstraZeneca

       Company Overview

       Business Strategies

       Financial Performance

3.1.5.5. GlaxoSmithKline

       Company Overview

       Business Strategies

       Financial Performance

 

3.1.6. Macro Economic and Industry Indicators: Current and Projections

3.1.6.1. Population, 2005-2015

3.1.6.2. Inpatient Admissions & Outpatients Visits, 2005-2010

3.1.6.3. Number of People with Health Insurance, 2005-2010

3.1.6.4. Prescription Drug Price index, 2005-2015

3.1.6.5. Personal Disposable Income, 2005-2015

 

3.2.        The US Agricultural Biotechnology Market Size and Introduction 2006-2011

3.2.1. The US Agricultural Biotechnology Market Segmentation, 2006-2011

3.2.2. The US Biotechnology Crop Market Size, 2006-2011

3.2.2.1. By Crop Area, 2006-2011

3.2.2.2. By Revenue, 2006-2011

3.2.3. The US Biotechnology Crop Market Future Outlook/Projections, 2012-2016

3.2.3.1. By Crop Area and Revenue, 2012-2016

3.2.4. The US Bio-Pesticides Market Size and Introduction, 2006-2011

3.2.5. The US Bio-Pesticides Market Future Outlook and Projections, 2012-2016

3.2.6. The US Agriculture Biotechnology Market Trends and Developments

       Labeling of GM Food in The US Market

          The US Supermarkets Selling Privately Labeled Organic Products

3.2.7. The US Agricultural Biotechnology Future Outlook and Projections 2012-2016

3.2.8. Company Profiles of Major Companies in the US Agricultural Biotechnology Market

 

3.3.        The US Industrial Biotechnology Market Size and Introduction 2006-2011

3.3.1. The US Industrial Biotechnology Market Segmentation, 2006-2011

3.3.2. The US Biofuel Market Size by Revenue, 2006-2011

3.3.2.1. The US Biofuel Market Size by Production and Consumption, 2005-2011

3.3.2.2. The US Fuel Ethanol Import, 2005-2011

3.3.2.3. The US Bio Diesel Import and Export, 2005-2011

 

3.3.3. The US Biofuel Market Segmentation, 2006-2011

3.3.3.1. By Fuel Ethanol and Bio Diesel, 2006-2011

3.3.4. The US Biofuel Industry Future Projections, 2012-2016

3.3.4.1. By Value, 2012-2016

3.3.4.2. By Fuel Ethanol and Bio Diesel, 2012-2016

3.3.5. The US Bio-Enzymes Market Size by Revenue, 2006-2011

 

3.3.6. Company Profiles of Major Companies in US Bio-Enzymes Market, 2011

3.3.6.1. Novozymes

       Company Overview

       Business Strategies

       Financial Performance

3.3.6.2. Genencor

       Company Overview

       Business Strategies

       Financial Performance

3.3.7. The US Bio-Enzymes Market Future Outlook and Projections, 2012-2016

3.3.8. The US Industrial Biotechnology Market Trends And Developments

        Increasing Government Blending Rate Targets

       Shifting Focus Towards Advanced Biofuels

       Growing Application of Industrial Enzymes For Biofuels

3.3.9. The US Industrial Biotechnology Future Outlook and Projections, 2012-2016

 

4.        The US Biotechnology Market Future Outlook and Projections

4.1.        Cause and Effect Relationship Between Industry Factors and The US Biotechnology Industry

 

5.        Appendix

5.1.        Market Definitions

5.2.        Abbreviations

5.3.        Research Methodology

       Data Collection Methods

       Approach

       Variables (Dependent and Independent) 

       Multi Factor Based Sensitivity Model

       Scenario Analysis

       Final Conclusion

5.4.        Disclaimer

 

To know more information on Purchase by Section, please send a mail toinfo@kenresearch.com